The Soudry Lab

תמונה ראשית- Soudri lab

The Soudry Lab

Therapeutic Avenues for Retinal Neurodegenerations

Principal Investigator: Dr. Shiri Zayit-Soudry

Our group focuses on exploring processes of molecular self-assembly occurring in disease states in the eye, and their importance in major retinal disorders. We hypothesize that various peptides and metabolites accumulating in retinal degenerations can self-assemble into cytotoxic structures, which may play a role in the pathogenesis of the retinopathy. Such conceptual and mechanistic insights will establish the basis for further experiments, investigating whether targeting the pathogenic aggregates can impact their mediated retinal damage, and will guide the rational development of novel therapeutic avenues for retinal neurodegenerations.

Meet the Soudry Lab Team>

The Soudry Lab

Dr. Shiri Zayit-Soudry

Dr. Shiri Soudry is an Attending Physician in the Ophthalmology Department of the Rambam Health Care Campus, and a faculty member of the Rappaport Faculty of Medicine of the Technion-Israel Institute of Technology.

Dr. Soudry earned her medical degree from the Rappaport Faculty of Medicine, and completed her Ophthalmology residency training at the Tel Aviv Medical Center. She then completed a 2-year advanced Medical/Surgical Retina Fellowship at the Wilmer Eye Institute of the Johns Hopkins University School of Medicine in Baltimore, MD. She carried on to complete another two year Clinical/Research fellowship training in the field of Inherited Retinal Diseases/Retinal Degenerations and Advanced Retina Imaging at the Retina Unit of University of California, San Francisco. She joined the Rambam faculty in 2014.